DEXMEDETOMIDINE HYDROCHLORIDE

DEXMEDETOMIDINE HYDROCHLORIDE was reported 3002 times

DEXMEDETOMIDINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEONATAL HYPERGLYCAEMIA 10 0.2703
1 TRANSCRANIAL ELECTRICAL MOTOR EVOKED POTENTIAL MONITORING ABNORMAL 8 0.2424
2 REEXPANSION PULMONARY OEDEMA 2 0.1667
3 NASOGASTRIC OUTPUT HIGH 2 0.1667
4 PHRENIC NERVE INJURY 3 0.1500
5 HEART RATE VARIABILITY DECREASED 4 0.0976
6 BURKHOLDERIA TEST POSITIVE 11 0.0887
7 GLOSSOPTOSIS 19 0.0868
8 PARATONIA 2 0.0769
9 VENTRICULAR PRE-EXCITATION 2 0.0645
10 LUNG ASSIST DEVICE THERAPY 4 0.0645
11 TRIGEMINO-CARDIAC REFLEX 5 0.0617
12 INFANT IRRITABILITY 6 0.0612
13 BEZOLD-JARISCH REFLEX 2 0.0526
14 HYPOCAPNIA 22 0.0526
15 MYOCARDIAL CALCIFICATION 6 0.0513
16 POSTOPERATIVE DELIRIUM 10 0.0505
17 CHOLINERGIC REBOUND SYNDROME 2 0.0488
18 NEGATIVE PRESSURE PULMONARY OEDEMA 4 0.0408
19 FLOPPY IRIS SYNDROME 15 0.0407
20 ELECTROCARDIOGRAM R ON T PHENOMENON 2 0.0400
21 BASELINE FOETAL HEART RATE VARIABILITY DISORDER 2 0.0364
22 UPPER AIRWAY OBSTRUCTION 32 0.0361
23 HYPERCAPNIC COMA 5 0.0352
24 ERYTHROBLAST COUNT INCREASED 2 0.0333
25 CENTRAL VENOUS PRESSURE INCREASED 4 0.0328
26 NEONATAL DYSPNOEA 3 0.0316
27 POSTRESUSCITATION ENCEPHALOPATHY 2 0.0312
28 HYPOTENSIVE TRANSFUSION REACTION 2 0.0303
29 MECHANICAL VENTILATION COMPLICATION 4 0.0268
30 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 2 0.0267
31 RED BLOOD CELL ELLIPTOCYTES PRESENT 2 0.0260
32 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 9 0.0256
33 RENAL ISCHAEMIA 14 0.0256
34 WITHDRAWAL HYPERTENSION 5 0.0248
35 LARYNGEAL STENOSIS 14 0.0242
36 DIABETES INSIPIDUS 58 0.0241
37 PHAEOCHROMOCYTOMA CRISIS 5 0.0236
38 AIRWAY COMPLICATION OF ANAESTHESIA 6 0.0228
39 NEONATAL RESPIRATORY DEPRESSION 7 0.0211
40 SINUS ARREST 31 0.0198
41 ACUTE MOTOR AXONAL NEUROPATHY 2 0.0192
42 NEONATAL HYPOTENSION 7 0.0190
43 OBSTRUCTIVE SHOCK 2 0.0183
44 GAMMA-GLUTAMYLTRANSFERASE 2 0.0183
45 ACQUIRED FACTOR V DEFICIENCY 2 0.0182
46 DRUG HALF-LIFE INCREASED 2 0.0175
47 VENTRICULAR ASYSTOLE 3 0.0172
48 INTESTINAL PSEUDO-OBSTRUCTION 15 0.0171
49 IRREGULAR BREATHING 10 0.0170
50 DELAYED RECOVERY FROM ANAESTHESIA 16 0.0169
51 SEDATION COMPLICATION 42 0.0164
52 ARTERIOSPASM CORONARY 64 0.0159
53 RHYTHM IDIOVENTRICULAR 5 0.0154
54 HYPERTHERMIA MALIGNANT 22 0.0148
55 HAPTOGLOBIN INCREASED 2 0.0146
56 CARDIAC ARREST NEONATAL 2 0.0145
57 INFANTILE APNOEA 11 0.0135
58 PRODUCT APPEARANCE CONFUSION 12 0.0130
59 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 79 0.0130
60 SEIZURE LIKE PHENOMENA 22 0.0129
61 VENTRICULAR FAILURE 4 0.0128
62 FACTOR V DEFICIENCY 2 0.0125
63 NERVE CONDUCTION STUDIES ABNORMAL 2 0.0120
64 MEAN ARTERIAL PRESSURE DECREASED 3 0.0119
65 ENTEROVIRUS TEST POSITIVE 2 0.0115
66 DRUG WITHDRAWAL CONVULSIONS 20 0.0112
67 PRINZMETAL ANGINA 11 0.0111
68 EXAGGERATED STARTLE RESPONSE 2 0.0109
69 PRODUCT CLOSURE REMOVAL DIFFICULT 11 0.0108
70 LYMPHOCYTE PERCENTAGE INCREASED 4 0.0099
71 ECHOLALIA 3 0.0094
72 CENTRAL SLEEP APNOEA SYNDROME 3 0.0092
73 PHRENIC NERVE PARALYSIS 2 0.0091
74 BRADYARRHYTHMIA 15 0.0091
75 CARDIAC OUTPUT DECREASED 8 0.0091
76 SHUNT INFECTION 2 0.0088
77 ALBUMIN GLOBULIN RATIO DECREASED 2 0.0086
78 ACQUIRED DIAPHRAGMATIC EVENTRATION 3 0.0085
79 CEREBROVASCULAR INSUFFICIENCY 2 0.0083
80 WEANING FAILURE 3 0.0082
81 PNEUMONIA HAEMOPHILUS 4 0.0082
82 ELECTROCARDIOGRAM P WAVE ABNORMAL 2 0.0082
83 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 3 0.0079
84 SHUNT OCCLUSION 4 0.0079
85 TRACHEOBRONCHITIS 6 0.0078
86 OXYGEN SATURATION 2 0.0076
87 RESPIRATORY ACIDOSIS 29 0.0074
88 ANTITHROMBIN III DECREASED 2 0.0073
89 PRODUCT CLOSURE ISSUE 4 0.0072
90 COLONIC PSEUDO-OBSTRUCTION 2 0.0072
91 POSTOPERATIVE FEVER 2 0.0071
92 SECONDARY HYPERTENSION 2 0.0070
93 ATRIOVENTRICULAR BLOCK SECOND DEGREE 21 0.0069
94 HYPORESPONSIVE TO STIMULI 8 0.0068
95 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
96 SINOATRIAL BLOCK 4 0.0067
97 DEVICE COMPUTER ISSUE 2 0.0067
98 ANAESTHETIC COMPLICATION NEUROLOGICAL 6 0.0066
99 NEUROLOGICAL EXAMINATION ABNORMAL 3 0.0064
100 DEVICE PROGRAMMING ERROR 2 0.0063
101 ELECTROMECHANICAL DISSOCIATION 5 0.0063
102 BLOOD OSMOLARITY INCREASED 2 0.0061
103 NEONATAL HYPOXIA 5 0.0060
104 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 43 0.0060
105 LARYNGOMALACIA 2 0.0060
106 PROPOFOL INFUSION SYNDROME 4 0.0057
107 DRUG-GENETIC INTERACTION 2 0.0056
108 ORAL DISCHARGE 2 0.0055
109 ACCIDENT AT WORK 12 0.0054
110 ELECTROCARDIOGRAM PR PROLONGATION 4 0.0052
111 HYPERNATRAEMIA 26 0.0052
112 LARYNGOSPASM 14 0.0052
113 ELECTROENCEPHALOGRAM ABNORMAL 16 0.0051
114 CATHETER SITE EXTRAVASATION 2 0.0050
115 TORSADE DE POINTES 39 0.0050
116 PRODUCT PACKAGING CONFUSION 12 0.0049
117 BRADYCARDIA 259 0.0049
118 HAEMOBILIA 2 0.0048
119 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7 0.0048
120 CANDIDA TEST POSITIVE 2 0.0048
121 NODAL RHYTHM 7 0.0048
122 BACILLUS INFECTION 3 0.0047
123 VENTRICULAR DYSFUNCTION 12 0.0046
124 VASOCONSTRICTION 4 0.0046
125 BLOOD LACTIC ACID INCREASED 24 0.0046
126 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
127 HYPERTHERMIA 34 0.0044
128 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
129 ATRIOVENTRICULAR BLOCK COMPLETE 29 0.0043
130 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 14 0.0042
131 VIRAL HAEMORRHAGIC CYSTITIS 3 0.0042
132 MENINGITIS BACTERIAL 6 0.0042
133 RESPIRATORY DEPRESSION 51 0.0042
134 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
135 HYPERCALCIURIA 2 0.0041
136 MATERNAL EXPOSURE DURING DELIVERY 4 0.0040
137 HYPERCAPNIA 12 0.0040
138 RETROGRADE AMNESIA 2 0.0040
139 APNOEA 30 0.0038
140 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 3 0.0038
141 HYPOTONIA NEONATAL 6 0.0038
142 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
143 MYOGLOBINURIA 2 0.0038
144 LYMPHOCYTE STIMULATION TEST POSITIVE 3 0.0037
145 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
146 PRODUCT NAME CONFUSION 4 0.0037
147 RETINOPATHY OF PREMATURITY 2 0.0036
148 ENDOTRACHEAL INTUBATION 10 0.0036
149 VENTRICULAR FIBRILLATION 39 0.0035
150 NODAL ARRHYTHMIA 3 0.0035
151 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
152 MEDIASTINITIS 2 0.0034
153 ABDOMINAL MASS 9 0.0034
154 CANDIDA SEPSIS 3 0.0033
155 MEAN PLATELET VOLUME INCREASED 2 0.0033
156 SINUS BRADYCARDIA 32 0.0033
157 HYPERPYREXIA 14 0.0033
158 HAEMODYNAMIC INSTABILITY 25 0.0033
159 WRONG PRODUCT ADMINISTERED 22 0.0033
160 NEONATAL RESPIRATORY DISTRESS 3 0.0032
161 BRADYCARDIA NEONATAL 4 0.0032
162 ABDOMINAL COMPARTMENT SYNDROME 2 0.0031
163 HYPERCHLORAEMIA 2 0.0031
164 METABOLIC ALKALOSIS 5 0.0031
165 ANOXIC ENCEPHALOPATHY 2 0.0031
166 KLEBSIELLA TEST POSITIVE 2 0.0031
167 SINUS ARRHYTHMIA 4 0.0031
168 PNEUMONIA STAPHYLOCOCCAL 6 0.0030
169 MITRAL VALVE STENOSIS 2 0.0030
170 FOETAL EXPOSURE DURING DELIVERY 2 0.0029
171 CARDIAC TAMPONADE 14 0.0029
172 OESOPHAGITIS ULCERATIVE 2 0.0029
173 CYTOKINE STORM 2 0.0029
174 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
175 RESPIRATORY RATE DECREASED 9 0.0029
176 SJS-TEN OVERLAP 2 0.0028
177 PROTHROMBIN TIME PROLONGED 17 0.0028
178 CEREBRAL ARTERY OCCLUSION 3 0.0028
179 DYSLALIA 2 0.0028
180 APALLIC SYNDROME 2 0.0028
181 SINUS NODE DYSFUNCTION 5 0.0027
182 DRUG-DISEASE INTERACTION 2 0.0027
183 PRODUCT PACKAGE ASSOCIATED INJURY 6 0.0027
184 BRAIN STEM SYNDROME 2 0.0027
185 THYROTOXIC CRISIS 3 0.0026
186 BLOOD FIBRINOGEN DECREASED 3 0.0026
187 TRACHEITIS 2 0.0026
188 PNEUMONIA PSEUDOMONAL 4 0.0026
189 PULMONARY MYCOSIS 2 0.0026
190 POLYURIA 21 0.0026
191 EXTRADURAL ABSCESS 2 0.0025
192 ACUTE LUNG INJURY 3 0.0025
193 PRODUCT CONFUSION 2 0.0025
194 ESCHERICHIA TEST POSITIVE 3 0.0025
195 LONG QT SYNDROME 6 0.0025
196 BRONCHOPULMONARY DYSPLASIA 2 0.0025
197 VENTRICULAR TACHYCARDIA 41 0.0025
198 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
199 PSEUDOMONAS TEST POSITIVE 2 0.0024
200 SEIZURE CLUSTER 2 0.0024
201 HYPOTONIA 24 0.0024
202 INFUSION SITE OEDEMA 2 0.0024
203 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 2 0.0024
204 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
205 INCREASED BRONCHIAL SECRETION 6 0.0023
206 APGAR SCORE LOW 3 0.0023
207 SLOW RESPONSE TO STIMULI 3 0.0023
208 ENTEROVIRUS INFECTION 2 0.0023
209 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
210 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
211 ENTEROCUTANEOUS FISTULA 2 0.0023
212 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
213 HYPERLACTACIDAEMIA 6 0.0022
214 ANAEMIA OF CHRONIC DISEASE 2 0.0022
215 PROTEIN URINE 2 0.0022
216 SELECTIVE EATING DISORDER 2 0.0022
217 EXTRAVASATION 9 0.0022
218 MYOCLONUS 26 0.0022
219 PNEUMONIA KLEBSIELLA 4 0.0022
220 HYPOTHERMIA 22 0.0022
221 CATHETER PLACEMENT 4 0.0022
222 BILIRUBIN CONJUGATED INCREASED 5 0.0021
223 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
224 HEPATIC CONGESTION 2 0.0021
225 CARDIAC ARREST 174 0.0021
226 COMMUNICATION DISORDER 8 0.0021
227 ATELECTASIS 20 0.0021
228 ADENOVIRUS INFECTION 6 0.0021
229 HAEMOTHORAX 6 0.0021
230 STRESS CARDIOMYOPATHY 12 0.0021
231 GENERALISED TONIC-CLONIC SEIZURE 34 0.0021
232 CONTINUOUS HAEMODIAFILTRATION 2 0.0020
233 IDIOSYNCRATIC DRUG REACTION 2 0.0020
234 SUBCUTANEOUS EMPHYSEMA 2 0.0020
235 SPUTUM RETENTION 2 0.0020
236 SYSTEMIC CANDIDA 5 0.0020
237 TACHYPNOEA 27 0.0020
238 ACIDOSIS 15 0.0020
239 BLADDER DYSFUNCTION 2 0.0019
240 CAROTID ARTERIOSCLEROSIS 2 0.0019
241 BRUGADA SYNDROME 2 0.0019
242 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
243 ASTERIXIS 2 0.0019
244 JOINT CONTRACTURE 2 0.0019
245 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0018
246 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
247 RIGHT VENTRICULAR DYSFUNCTION 2 0.0018
248 ILEUS PARALYTIC 8 0.0018
249 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
250 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
251 BLOOD ALBUMIN DECREASED 14 0.0018
252 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
253 CARBON DIOXIDE DECREASED 2 0.0017
254 BLOOD CHLORIDE INCREASED 3 0.0017
255 NEUROLOGICAL DECOMPENSATION 4 0.0017
256 HYPOPNOEA 6 0.0017
257 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
258 OBSTRUCTIVE AIRWAYS DISORDER 19 0.0017
259 PULSE ABSENT 8 0.0017
260 GRAFT VERSUS HOST DISEASE 12 0.0017
261 ACUTE RESPIRATORY FAILURE 32 0.0017
262 STARING 4 0.0017
263 DEVICE ALARM ISSUE 3 0.0017
264 ENCEPHALITIS VIRAL 2 0.0016
265 ASPIRATION 18 0.0016
266 INFUSION SITE WARMTH 2 0.0016
267 PARADOXICAL DRUG REACTION 6 0.0016
268 MULTI-ORGAN FAILURE 28 0.0016
269 HYPOXIA 57 0.0016
270 DEVICE INFUSION ISSUE 4 0.0016
271 TOXIC ENCEPHALOPATHY 8 0.0016
272 BRONCHIAL SECRETION RETENTION 2 0.0016
273 PLATELET TRANSFUSION 2 0.0016
274 ABDOMINAL WALL ABSCESS 1 0.0015
275 HYPOVENTILATION 5 0.0015
276 ANAEMIA POSTOPERATIVE 2 0.0015
277 OXYGEN SATURATION DECREASED 86 0.0015
278 HYPERAEMIA 3 0.0015
279 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
280 CARDIAC FAILURE ACUTE 10 0.0015
281 ANION GAP INCREASED 2 0.0015
282 BRADYPNOEA 4 0.0015
283 QUADRIPLEGIA 3 0.0015
284 INFUSION SITE EXTRAVASATION 9 0.0014
285 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
286 ANTICONVULSANT DRUG LEVEL DECREASED 2 0.0014
287 TONIC CONVULSION 2 0.0014
288 OXYGEN SATURATION ABNORMAL 4 0.0014
289 HYPERAMMONAEMIA 7 0.0014
290 HYPERPHOSPHATAEMIA 3 0.0014
291 PORPHYRIA ACUTE 2 0.0014
292 CARDIOGENIC SHOCK 20 0.0014
293 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
294 CLOSTRIDIUM TEST POSITIVE 3 0.0014
295 STRIDOR 4 0.0014
296 COVID-19 PNEUMONIA 16 0.0014
297 INFUSION SITE INDURATION 2 0.0013
298 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
299 HEPATITIS FULMINANT 4 0.0013
300 INTERCEPTED DRUG DISPENSING ERROR 2 0.0013
301 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
302 METABOLIC ENCEPHALOPATHY 4 0.0013
303 EYE MOVEMENT DISORDER 9 0.0013
304 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
305 MYOGLOBIN BLOOD INCREASED 2 0.0013
306 BLOOD PRESSURE IMMEASURABLE 2 0.0013
307 PANCREATITIS NECROTISING 3 0.0013
308 PROCEDURAL COMPLICATION 10 0.0013
309 ATRIOVENTRICULAR BLOCK 10 0.0013
310 ILEUS 16 0.0013
311 RIGHT VENTRICULAR FAILURE 9 0.0013
312 PNEUMONIA ASPIRATION 32 0.0013
313 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
314 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
315 HYPOVOLAEMIC SHOCK 6 0.0013
316 MIOSIS 10 0.0012
317 DISINHIBITION 2 0.0012
318 DELIRIUM 43 0.0012
319 ANTICONVULSANT DRUG LEVEL INCREASED 2 0.0012
320 RESPIRATORY ALKALOSIS 2 0.0012
321 PULMONARY ARTERIAL PRESSURE INCREASED 2 0.0012
322 ACUTE PSYCHOSIS 3 0.0012
323 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
324 SEPTIC SHOCK 52 0.0012
325 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
326 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
327 RESPIRATORY FAILURE 86 0.0012
328 CIRCULATORY COLLAPSE 20 0.0012
329 GAZE PALSY 2 0.0012
330 LACERATION 11 0.0012
331 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
332 UNRESPONSIVE TO STIMULI 30 0.0012
333 PUPIL FIXED 2 0.0012
334 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
335 STATUS EPILEPTICUS 13 0.0011
336 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
337 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
338 URINE OUTPUT INCREASED 3 0.0011
339 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
340 MYOCARDIAL ISCHAEMIA 13 0.0011
341 MITRAL VALVE DISEASE 2 0.0011
342 ANAESTHETIC COMPLICATION 3 0.0011
343 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
344 AGITATION 82 0.0011
345 PNEUMOMEDIASTINUM 2 0.0011
346 CEREBRAL VENOUS THROMBOSIS 2 0.0011
347 HEPATIC FUNCTION ABNORMAL 41 0.0011
348 IMMUNE-MEDIATED LUNG DISEASE 2 0.0011
349 ANAPHYLACTIC SHOCK 28 0.0011
350 PNEUMOPERITONEUM 2 0.0011
351 RASH MORBILLIFORM 3 0.0011
352 GRANULOCYTE COUNT DECREASED 2 0.0011
353 HEART RATE ABNORMAL 6 0.0011
354 WITHDRAWAL SYNDROME 45 0.0011
355 BLOOD PRESSURE DECREASED 71 0.0011
356 PROTEIN TOTAL DECREASED 4 0.0011
357 SINUS TACHYCARDIA 15 0.0011
358 MECHANICAL VENTILATION 2 0.0011
359 SHOCK 24 0.0010
360 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
361 THROMBOTIC MICROANGIOPATHY 10 0.0010
362 CARDIOPULMONARY FAILURE 4 0.0010
363 ACUTE RESPIRATORY DISTRESS SYNDROME 18 0.0010
364 MULTI-ORGAN DISORDER 2 0.0010
365 RESPIRATORY DISTRESS 28 0.0010
366 ACCIDENTAL OVERDOSE 37 0.0010
367 RHABDOMYOLYSIS 42 0.0010
368 HYPERTRANSAMINASAEMIA 7 0.0010
369 EMPYEMA 2 0.0010
370 BRAIN HERNIATION 3 0.0010
371 MUCOSAL DRYNESS 2 0.0010
372 SEDATION 26 0.0010
373 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
374 EMBOLISM VENOUS 3 0.0010
375 HYPERTENSIVE CRISIS 11 0.0010
376 DRUG TOLERANCE 5 0.0010
377 DYSPHORIA 5 0.0010
378 DEPRESSED LEVEL OF CONSCIOUSNESS 39 0.0010
379 PERIPHERAL ISCHAEMIA 4 0.0010
380 DIVERTICULAR PERFORATION 2 0.0010
381 BRAIN DEATH 3 0.0010
382 VENTRICULAR EXTRASYSTOLES 10 0.0010
383 SUBILEUS 2 0.0010
384 LIVEDO RETICULARIS 2 0.0010
385 ATRIAL TACHYCARDIA 2 0.0010
386 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
387 DEVICE CONNECTION ISSUE 2 0.0009
388 OCULOGYRIC CRISIS 2 0.0009
389 LYMPHOCYTOSIS 2 0.0009
390 SPUTUM INCREASED 2 0.0009
391 URINE OUTPUT DECREASED 8 0.0009
392 HEART RATE DECREASED 32 0.0009
393 CARDIO-RESPIRATORY ARREST 38 0.0009
394 INTESTINAL ISCHAEMIA 5 0.0009
395 HYPOTENSION 182 0.0009
396 RESPIRATORY ARREST 25 0.0009
397 CEREBRAL INFARCTION 22 0.0009
398 BACTERIAL TEST POSITIVE 2 0.0009
399 ACUTE PULMONARY OEDEMA 5 0.0009
400 ELECTROCARDIOGRAM QT PROLONGED 32 0.0009
401 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
402 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
403 SUSPECTED OFF LABEL USE 4 0.0009
404 BLOOD LOSS ANAEMIA 2 0.0009
405 PNEUMOTHORAX 14 0.0009
406 KOUNIS SYNDROME 2 0.0009
407 METASTASES TO MENINGES 2 0.0009
408 LICHENOID KERATOSIS 2 0.0009
409 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
410 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
411 PRODUCT LABEL CONFUSION 5 0.0009
412 ENCEPHALOPATHY 21 0.0009
413 NECROTISING FASCIITIS 3 0.0009
414 HAEMORRHAGIC DIATHESIS 3 0.0008
415 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
416 LACUNAR INFARCTION 2 0.0008
417 TACHYCARDIA 74 0.0008
418 MONOCYTE COUNT INCREASED 3 0.0008
419 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
420 CEREBRAL DISORDER 6 0.0008
421 CARDIAC DYSFUNCTION 3 0.0008
422 LEUKOENCEPHALOPATHY 3 0.0008
423 INTESTINAL PERFORATION 9 0.0008
424 HYPERGLYCAEMIA 29 0.0008
425 CORONARY ARTERY STENOSIS 4 0.0008
426 MENTAL STATUS CHANGES 22 0.0008
427 EXCORIATION 2 0.0008
428 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
429 POST PROCEDURAL COMPLICATION 15 0.0008
430 PHYSICAL DECONDITIONING 2 0.0008
431 ELECTROLYTE IMBALANCE 9 0.0008
432 THERAPY PARTIAL RESPONDER 12 0.0008
433 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
434 RADICULOPATHY 2 0.0008
435 IDIOPATHIC PULMONARY FIBROSIS 3 0.0008
436 ATRIAL FLUTTER 6 0.0008
437 CYTOKINE RELEASE SYNDROME 15 0.0007
438 ABDOMINAL RIGIDITY 2 0.0007
439 APPLICATION SITE HAEMORRHAGE 2 0.0007
440 RED BLOOD CELL COUNT INCREASED 2 0.0007
441 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
442 GASTROINTESTINAL PERFORATION 3 0.0007
443 HAEMODIALYSIS 6 0.0007
444 CHOLECYSTITIS ACUTE 4 0.0007
445 VOMITING PROJECTILE 2 0.0007
446 DYSPNOEA AT REST 2 0.0007
447 HYPERVENTILATION 4 0.0007
448 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
449 TUMOUR LYSIS SYNDROME 6 0.0007
450 WRONG DRUG ADMINISTERED 6 0.0007
451 MIXED LIVER INJURY 2 0.0007
452 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
453 DIASTOLIC DYSFUNCTION 2 0.0006
454 NEPHROGENIC ANAEMIA 3 0.0006
455 OLIGURIA 4 0.0006
456 HYPOALBUMINAEMIA 5 0.0006
457 EOSINOPHILIC PNEUMONIA 2 0.0006
458 BILE DUCT STONE 2 0.0006
459 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
460 VENTRICULAR HYPOKINESIA 2 0.0006
461 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
462 DEAFNESS NEUROSENSORY 2 0.0006
463 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
464 POST PROCEDURAL HAEMORRHAGE 7 0.0006
465 BLOOD UREA INCREASED 10 0.0006
466 POST-TRAUMATIC STRESS DISORDER 4 0.0006
467 SEPSIS 66 0.0006
468 BACTERAEMIA 7 0.0006
469 PHLEBITIS 3 0.0006
470 WOUND COMPLICATION 2 0.0006
471 RESPIRATION ABNORMAL 4 0.0006
472 PARTIAL SEIZURES 3 0.0006
473 CHOLESTASIS 11 0.0006
474 TYPE I HYPERSENSITIVITY 2 0.0006
475 BRONCHIOLITIS 2 0.0006
476 EMBOLIC STROKE 2 0.0006
477 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
478 METABOLIC ACIDOSIS 18 0.0006
479 FIBRIN D DIMER INCREASED 2 0.0006
480 CONJUNCTIVAL HYPERAEMIA 2 0.0006
481 FEAR 15 0.0006
482 BLOOD BILIRUBIN INCREASED 15 0.0006
483 HYDROCEPHALUS 3 0.0006
484 DEVICE KINK 2 0.0005
485 VENTRICULAR ARRHYTHMIA 2 0.0005
486 DRUG LEVEL INCREASED 9 0.0005
487 DRUG INTERACTION 86 0.0005
488 AMYLASE INCREASED 2 0.0005
489 MALNUTRITION 6 0.0005
490 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
491 PULMONARY HYPERTENSION 11 0.0005
492 ALANINE AMINOTRANSFERASE INCREASED 32 0.0005
493 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
494 LIVER DISORDER 23 0.0005
495 SYRINGE ISSUE 9 0.0005
496 RHINOVIRUS INFECTION 2 0.0005
497 LIVER FUNCTION TEST INCREASED 11 0.0005
498 PULMONARY HAEMORRHAGE 4 0.0005
499 RENAL TUBULAR NECROSIS 5 0.0005
500 RENAL INJURY 15 0.0005
501 CEREBRAL ATROPHY 2 0.0005
502 DRUG WITHDRAWAL SYNDROME 44 0.0005
503 SALIVARY HYPERSECRETION 5 0.0005
504 RESTLESSNESS 18 0.0005
505 SHOCK HAEMORRHAGIC 4 0.0005
506 PULMONARY OEDEMA 22 0.0005
507 PRODUCT USE ISSUE 92 0.0005
508 CARDIOMEGALY 6 0.0005
509 HICCUPS 4 0.0005
510 AORTIC DISSECTION 2 0.0005
511 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
512 ACUTE CORONARY SYNDROME 4 0.0005
513 HYPERBILIRUBINAEMIA 5 0.0005
514 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
515 ACUTE KIDNEY INJURY 73 0.0005
516 FEBRILE NEUTROPENIA 31 0.0005
517 HEPATIC FAILURE 14 0.0005
518 MONOPLEGIA 2 0.0005
519 BLOOD PRESSURE FLUCTUATION 11 0.0005
520 HYPOGAMMAGLOBULINAEMIA 3 0.0005
521 HYPOKALAEMIA 21 0.0005
522 DEVICE RELATED INFECTION 7 0.0005
523 HAEMATOCRIT DECREASED 9 0.0005
524 MENINGITIS 3 0.0004
525 LIVER INJURY 11 0.0004
526 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
527 CEREBRAL HAEMORRHAGE 16 0.0004
528 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
529 RENAL IMPAIRMENT 37 0.0004
530 HAEMOGLOBIN INCREASED 2 0.0004
531 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
532 PNEUMONIA BACTERIAL 4 0.0004
533 BRONCHOSPASM 6 0.0004
534 MUSCLE RIGIDITY 5 0.0004
535 PLATELET COUNT DECREASED 44 0.0004
536 ADRENAL INSUFFICIENCY 5 0.0004
537 PLEURAL EFFUSION 25 0.0004
538 MELAENA 9 0.0004
539 PRODUCT USE IN UNAPPROVED INDICATION 101 0.0004
540 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
541 HYPOPHOSPHATAEMIA 3 0.0004
542 INJECTION SITE EXTRAVASATION 5 0.0004
543 STAPHYLOCOCCAL SEPSIS 2 0.0004
544 INFLAMMATORY MARKER INCREASED 2 0.0004
545 RESPIRATORY DISORDER 12 0.0004
546 ATRIAL FIBRILLATION 39 0.0004
547 BRAIN INJURY 4 0.0004
548 ANAPHYLACTIC REACTION 22 0.0004
549 PRODUCT ADMINISTRATION ERROR 8 0.0004
550 KLEBSIELLA INFECTION 2 0.0004
551 TROPONIN INCREASED 3 0.0004
552 DYSLIPIDAEMIA 2 0.0004
553 DYSKINESIA 16 0.0004
554 MOTOR DYSFUNCTION 4 0.0004
555 HEPATIC CYTOLYSIS 5 0.0004
556 AMMONIA INCREASED 2 0.0004
557 ABDOMINAL INFECTION 1 0.0004
558 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
559 FEMORAL NECK FRACTURE 2 0.0004
560 ENDOCARDITIS 2 0.0004
561 PERICARDIAL EFFUSION 9 0.0004
562 CEREBRAL ISCHAEMIA 2 0.0004
563 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
564 FOETAL DEATH 2 0.0004
565 SKIN NECROSIS 2 0.0004
566 MALABSORPTION 2 0.0004
567 APLASTIC ANAEMIA 2 0.0004
568 DRUG-INDUCED LIVER INJURY 12 0.0004
569 TRANSFUSION 4 0.0004
570 CYANOSIS 6 0.0004
571 CATATONIA 2 0.0004
572 SERUM FERRITIN INCREASED 2 0.0004
573 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
574 NYSTAGMUS 2 0.0004
575 RENAL FAILURE 50 0.0004
576 PANCYTOPENIA 21 0.0004
577 MYASTHENIA GRAVIS 3 0.0004
578 HYPOCALCAEMIA 7 0.0004
579 ACUTE HEPATIC FAILURE 5 0.0004
580 HYPERAESTHESIA 3 0.0004
581 SEROTONIN SYNDROME 7 0.0004
582 SEIZURE 42 0.0004
583 GASTRIC ULCER HAEMORRHAGE 2 0.0004
584 HEMIPLEGIA 3 0.0004
585 NECROSIS 2 0.0004
586 INTRACRANIAL PRESSURE INCREASED 2 0.0004
587 COMA 17 0.0004
588 BLOOD CALCIUM DECREASED 4 0.0004
589 HEPATOCELLULAR INJURY 5 0.0004
590 CARDIAC FAILURE 28 0.0003
591 ANURIA 3 0.0003
592 CORONARY ARTERY BYPASS 2 0.0003
593 FLUID OVERLOAD 5 0.0003
594 BODY TEMPERATURE INCREASED 7 0.0003
595 ANHEDONIA 9 0.0003
596 HYPERTRIGLYCERIDAEMIA 2 0.0003
597 INJURY 24 0.0003
598 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
599 DRUG ERUPTION 6 0.0003
600 ATAXIA 4 0.0003
601 PYREXIA 116 0.0003
602 HAEMOLYTIC ANAEMIA 3 0.0003
603 HAEMORRHAGE INTRACRANIAL 5 0.0003
604 IRRITABILITY 20 0.0003
605 INTERSTITIAL LUNG DISEASE 16 0.0003
606 UNEVALUABLE EVENT 25 0.0003
607 RESTLESS LEGS SYNDROME 6 0.0003
608 FOETAL GROWTH RESTRICTION 2 0.0003
609 IRON DEFICIENCY ANAEMIA 3 0.0003
610 LARYNGEAL OEDEMA 2 0.0003
611 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
612 CHOLANGITIS 2 0.0003
613 LUNG INFECTION 5 0.0003
614 DIARRHOEA HAEMORRHAGIC 3 0.0003
615 SYNCOPE 32 0.0003
616 DYSARTHRIA 12 0.0003
617 INFUSION SITE SWELLING 2 0.0003
618 LOSS OF CONSCIOUSNESS 40 0.0003
619 DYSTONIA 6 0.0003
620 RASH GENERALISED 8 0.0003
621 PNEUMONIA 100 0.0003
622 PLATELET COUNT INCREASED 4 0.0003
623 ACUTE MYOCARDIAL INFARCTION 9 0.0003
624 BODY TEMPERATURE DECREASED 3 0.0003
625 ASPERGILLUS INFECTION 2 0.0003
626 PULMONARY CONGESTION 4 0.0003
627 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
628 COAGULOPATHY 5 0.0003
629 PREMATURE BABY 9 0.0003
630 POSTOPERATIVE WOUND INFECTION 2 0.0003
631 TOOTH ABSCESS 3 0.0003
632 SUBARACHNOID HAEMORRHAGE 3 0.0003
633 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
634 PERITONITIS 6 0.0003
635 DROOLING 2 0.0003
636 EYE DISCHARGE 3 0.0003
637 HYPOMAGNESAEMIA 4 0.0003
638 NEUROTOXICITY 5 0.0003
639 TOXICITY TO VARIOUS AGENTS 48 0.0003
640 DUODENAL ULCER 2 0.0003
641 RENAL FAILURE ACUTE 12 0.0003
642 DIALYSIS 4 0.0003
643 EXTRAPYRAMIDAL DISORDER 7 0.0003
644 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
645 RED BLOOD CELL COUNT DECREASED 8 0.0003
646 PARALYSIS 4 0.0003
647 DERMATITIS BULLOUS 2 0.0003
648 LEUKOCYTOSIS 5 0.0003
649 C-REACTIVE PROTEIN INCREASED 10 0.0003
650 ARRHYTHMIA 13 0.0003
651 HYPERTENSION 58 0.0003
652 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
653 MOUTH HAEMORRHAGE 2 0.0003
654 OFF LABEL USE 238 0.0003
655 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
656 CARDIOMYOPATHY 4 0.0003
657 NEUTROPHIL COUNT DECREASED 11 0.0003
658 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
659 REBOUND EFFECT 3 0.0003
660 APHASIA 8 0.0003
661 SOMNOLENCE 53 0.0003
662 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
663 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
664 BLOOD CREATININE INCREASED 17 0.0003
665 JAUNDICE 7 0.0003
666 OVERDOSE 56 0.0003
667 HAEMOLYSIS 2 0.0003
668 CAESAREAN SECTION 3 0.0003
669 PALLOR 7 0.0003
670 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
671 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
672 TRICUSPID VALVE INCOMPETENCE 2 0.0003
673 LOW BIRTH WEIGHT BABY 2 0.0003
674 HAEMOPTYSIS 7 0.0003
675 TRANSPLANT REJECTION 2 0.0002
676 MUSCLE TIGHTNESS 4 0.0002
677 BLOOD POTASSIUM INCREASED 4 0.0002
678 DECUBITUS ULCER 2 0.0002
679 LIVER FUNCTION TEST ABNORMAL 7 0.0002
680 ASCITES 7 0.0002
681 INFUSION SITE ERYTHEMA 2 0.0002
682 PRODUCT CONTAINER ISSUE 2 0.0002
683 PSEUDOMONAS INFECTION 2 0.0002
684 THROMBOCYTOPENIA 26 0.0002
685 PSYCHOLOGICAL TRAUMA 2 0.0002
686 HIATUS HERNIA 3 0.0002
687 PYELONEPHRITIS 2 0.0002
688 EPILEPSY 7 0.0002
689 EOSINOPHILIA 4 0.0002
690 HYPERKALAEMIA 8 0.0002
691 ORAL CANDIDIASIS 3 0.0002
692 HYPOGLYCAEMIA 11 0.0002
693 IMMUNOSUPPRESSION 2 0.0002
694 LUNG INFILTRATION 2 0.0002
695 ABDOMINAL ABSCESS 1 0.0002
696 PURPURA 2 0.0002
697 ISCHAEMIC STROKE 4 0.0002
698 PROCEDURAL PAIN 6 0.0002
699 BACTERIAL INFECTION 4 0.0002
700 NEPHROPATHY 2 0.0002
701 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
702 ARTERIOSCLEROSIS 2 0.0002
703 HAEMOGLOBIN DECREASED 21 0.0002
704 HEPATOMEGALY 2 0.0002
705 DISABILITY 4 0.0002
706 BLOOD PRESSURE ABNORMAL 4 0.0002
707 LEUKOPENIA 10 0.0002
708 AGGRESSION 10 0.0002
709 POOR QUALITY DEVICE USED 2 0.0002
710 NEUTROPHIL COUNT INCREASED 2 0.0002
711 EAR DISCOMFORT 2 0.0002
712 COGNITIVE DISORDER 9 0.0002
713 HEAD INJURY 6 0.0002
714 ANAEMIA 36 0.0002
715 PREMATURE DELIVERY 3 0.0002
716 DECREASED ACTIVITY 2 0.0002
717 LACTIC ACIDOSIS 6 0.0002
718 PNEUMONITIS 5 0.0002
719 CYTOMEGALOVIRUS INFECTION 3 0.0002
720 STEVENS-JOHNSON SYNDROME 4 0.0002
721 HEMIPARESIS 3 0.0002
722 SCAR 3 0.0002
723 MYOCARDITIS 2 0.0002
724 GASTRIC HAEMORRHAGE 2 0.0002
725 HEART RATE INCREASED 17 0.0002
726 PANCREATITIS 9 0.0002
727 URINARY INCONTINENCE 5 0.0002
728 DYSPHAGIA 16 0.0002
729 PULMONARY EMBOLISM 16 0.0002
730 CHOLECYSTITIS 2 0.0002
731 HYPERLIPIDAEMIA 2 0.0002
732 POLYNEUROPATHY 2 0.0002
733 END STAGE RENAL DISEASE 3 0.0002
734 CONDITION AGGRAVATED 50 0.0002
735 NO THERAPEUTIC RESPONSE 2 0.0002
736 CYTOPENIA 2 0.0002
737 MUSCLE SPASTICITY 2 0.0002
738 HAEMORRHAGE 17 0.0002
739 SMALL INTESTINAL OBSTRUCTION 2 0.0002
740 HYPERCALCAEMIA 2 0.0002
741 MEDICATION ERROR 9 0.0002
742 GENERALISED OEDEMA 2 0.0002
743 AGRANULOCYTOSIS 3 0.0002
744 POISONING 2 0.0002
745 BLOOD SODIUM DECREASED 3 0.0002
746 PRODUCT COMPLAINT 4 0.0002
747 PROTEINURIA 3 0.0002
748 CONVULSION 9 0.0002
749 LETHARGY 9 0.0002
750 MYDRIASIS 2 0.0002
751 THERAPY NON-RESPONDER 7 0.0002
752 PRESCRIBED OVERDOSE 3 0.0002
753 HAEMATOMA 4 0.0002
754 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
755 RESPIRATORY TRACT INFECTION 4 0.0002
756 SINUS DISORDER 3 0.0002
757 SARS-COV-2 TEST POSITIVE 2 0.0002
758 ABNORMAL BEHAVIOUR 6 0.0002
759 DISORIENTATION 6 0.0002
760 BONE MARROW FAILURE 3 0.0001
761 IMPAIRED GASTRIC EMPTYING 2 0.0001
762 PRODUCT PREPARATION ERROR 3 0.0001
763 HAEMATURIA 5 0.0001
764 NEOPLASM PROGRESSION 5 0.0001
765 COORDINATION ABNORMAL 2 0.0001
766 DERMATITIS 3 0.0001
767 BLISTER 8 0.0001
768 EMOTIONAL DISTRESS 17 0.0001
769 PARAESTHESIA ORAL 2 0.0001
770 DEEP VEIN THROMBOSIS 9 0.0001
771 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
772 FAECES DISCOLOURED 3 0.0001
773 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
774 MYELODYSPLASTIC SYNDROME 2 0.0001
775 INFECTION 20 0.0001
776 MENTAL DISORDER 6 0.0001
777 HYPOKINESIA 2 0.0001
778 GASTROENTERITIS 2 0.0001
779 MUSCULOSKELETAL STIFFNESS 12 0.0001
780 CONFUSIONAL STATE 22 0.0001
781 ANGIOEDEMA 6 0.0001
782 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
783 DRUG WITHDRAWAL SYNDROME NEONATAL 2 0.0001
784 RASH MACULO-PAPULAR 3 0.0001
785 IMMUNODEFICIENCY 2 0.0001
786 ABDOMINAL DISTENSION 14 0.0001
787 OSTEOPENIA 2 0.0001
788 OEDEMA 7 0.0001
789 NERVOUS SYSTEM DISORDER 4 0.0001
790 DISEASE PROGRESSION 15 0.0001
791 OBESITY 2 0.0001
792 RASH ERYTHEMATOUS 6 0.0001
793 MOVEMENT DISORDER 4 0.0001
794 CARDIAC FAILURE CONGESTIVE 10 0.0001
795 HYPONATRAEMIA 7 0.0001
796 METASTASES TO BONE 2 0.0001
797 DEVICE LEAKAGE 5 0.0001
798 MUCOSAL INFLAMMATION 3 0.0001
799 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
800 LYMPHOCYTE COUNT DECREASED 2 0.0001
801 DYSPNOEA 63 0.0001
802 VOMITING 52 0.0001
803 MOOD ALTERED 3 0.0001
804 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
805 SKIN LESION 3 0.0001
806 ANXIETY 31 0.0001
807 HAEMATOCHEZIA 6 0.0001
808 CONJUNCTIVITIS 2 0.0001
809 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
810 HEPATIC STEATOSIS 2 0.0001
811 RENAL DISORDER 5 0.0001
812 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
813 HALLUCINATION 8 0.0001
814 INFUSION RELATED REACTION 7 0.0001
815 CHRONIC KIDNEY DISEASE 8 0.0001
816 SLEEP APNOEA SYNDROME 2 0.0001
817 HYPERSOMNIA 3 0.0001
818 DRUG PRESCRIBING ERROR 2 0.0001
819 HEPATIC ENZYME INCREASED 7 0.0001
820 WHEEZING 6 0.0001
821 BLOOD POTASSIUM DECREASED 3 0.0001
822 DRUG ADMINISTRATION ERROR 3 0.0001
823 THERAPY CESSATION 5 0.0001
824 RIB FRACTURE 2 0.0001
825 EXPOSURE DURING PREGNANCY 6 0.0001
826 INTENTIONAL DRUG MISUSE 2 0.0001
827 HYPOTHYROIDISM 3 0.0001
828 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
829 PRODUCT PRESCRIBING ISSUE 2 0.0001
830 CONSTIPATION 20 0.0001
831 BLOOD PRESSURE INCREASED 14 0.0001
832 STAPHYLOCOCCAL INFECTION 3 0.0001
833 APPLICATION SITE PAIN 2 0.0001
834 FUNGAL INFECTION 3 0.0001
835 TRANSAMINASES INCREASED 2 0.0001
836 URINARY RETENTION 3 0.0001
837 HEPATOTOXICITY 2 0.0001
838 ORAL PAIN 2 0.0001
839 RASH PAPULAR 2 0.0001
840 CHROMATURIA 2 0.0001
841 HEART RATE IRREGULAR 2 0.0001
842 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
843 MUSCLE TWITCHING 2 0.0001
844 HYPERHIDROSIS 11 0.0001
845 LYMPHADENOPATHY 3 0.0001
846 TREMOR 14 0.0001
847 COMPLETED SUICIDE 7 0.0001
848 PRODUCT PRESCRIBING ERROR 2 0.0001
849 NO ADVERSE EVENT 15 0.0001
850 DRUG EFFECT INCOMPLETE 3 0.0001
851 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
852 CRYING 3 0.0001
853 STOMATITIS 5 0.0001
854 PRESYNCOPE 2 0.0001
855 UNDERDOSE 6 0.0001
856 DISCOMFORT 5 0.0001
857 DRUG INEFFECTIVE 107 0.0001
858 NEUTROPENIA 11 0.0001
859 OSTEONECROSIS OF JAW 2 0.0001
860 HYPERSENSITIVITY 15 0.0001
861 COVID-19 14 0.0001
862 CARDIOVASCULAR DISORDER 2 0.0001
863 PAIN 48 0.0001
864 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
865 INTENTIONAL OVERDOSE 5 0.0001
866 DRUG RESISTANCE 2 0.0001
867 ERYTHEMA 16 0.0001
868 URTICARIA 13 0.0001
869 SKIN ULCER 2 0.0001
870 AMNESIA 5 0.0001
871 CEREBROVASCULAR ACCIDENT 13 0.0001
872 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
873 GASTRITIS 2 0.0001
874 DEHYDRATION 10 0.0001
875 DEATH 64 0.0001
876 OEDEMA PERIPHERAL 9 0.0001
877 TREATMENT FAILURE 6 0.0001
878 INFLUENZA 8 0.0001
879 SLEEP DISORDER 5 0.0001
880 OSTEOARTHRITIS 3 0.0001
881 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
882 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
883 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
884 FEMUR FRACTURE 2 0.0001
885 SWOLLEN TONGUE 2 0.0001
886 DIARRHOEA 41 0.0001
887 MUSCULAR WEAKNESS 7 0.0001
888 SWELLING FACE 4 0.0001
889 CHOLELITHIASIS 2 0.0001
890 VIRAL INFECTION 2 0.0001
891 CHILLS 7 0.0001
892 RASH 26 0.0001
893 CELLULITIS 3 0.0001
894 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
895 URINARY TRACT INFECTION 10 0.0001
896 SPEECH DISORDER 3 0.0001
897 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
898 ABDOMINAL PAIN 13 0.0001
899 DRUG EFFECT DECREASED 3 0.0001
900 MYELOSUPPRESSION 2 0.0001
901 RASH PRURITIC 3 0.0001
902 NAUSEA 43 0.0001
903 CHEST PAIN 10 0.0001
904 EYE SWELLING 2 0.0001
905 SWELLING 5 0.0001
906 DYSPNOEA EXERTIONAL 2 0.0001
907 ASTHMA 6 0.0001
908 INTESTINAL OBSTRUCTION 2 0.0001
909 DEPRESSION 12 0.0001
910 COUGH 14 0.0000
911 THROMBOSIS 4 0.0000
912 THERAPEUTIC RESPONSE DECREASED 3 0.0000
913 SUICIDE ATTEMPT 3 0.0000
914 DRY MOUTH 4 0.0000
915 DEVICE BREAKAGE 2 0.0000
916 BLINDNESS 2 0.0000
917 LUNG NEOPLASM MALIGNANT 2 0.0000
918 RECTAL HAEMORRHAGE 2 0.0000
919 RHINORRHOEA 3 0.0000
920 MYOCARDIAL INFARCTION 8 0.0000
921 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
922 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
923 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
924 TINNITUS 2 0.0000
925 SKIN DISCOLOURATION 2 0.0000
926 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
927 ASTHENIA 16 0.0000
928 DISEASE RECURRENCE 2 0.0000
929 BLOOD GLUCOSE DECREASED 2 0.0000
930 DRUG INTOLERANCE 4 0.0000
931 BRONCHITIS 3 0.0000
932 ABASIA 1 0.0000
933 EPISTAXIS 3 0.0000
934 HYPOAESTHESIA 6 0.0000
935 INCORRECT DOSE ADMINISTERED 9 0.0000
936 FLUSHING 4 0.0000
937 FLUID RETENTION 2 0.0000
938 INJECTION SITE SWELLING 3 0.0000
939 ABDOMINAL PAIN UPPER 8 0.0000
940 NERVOUSNESS 2 0.0000
941 ECZEMA 2 0.0000
942 MUSCLE SPASMS 7 0.0000
943 FEELING ABNORMAL 9 0.0000
944 INSOMNIA 10 0.0000
945 DISTURBANCE IN ATTENTION 2 0.0000
946 FALL 12 0.0000
947 SKIN EXFOLIATION 3 0.0000
948 HERPES ZOSTER 2 0.0000
949 PALPITATIONS 4 0.0000
950 DEVICE ISSUE 3 0.0000
951 VERTIGO 2 0.0000
952 DRUG DEPENDENCE 5 0.0000
953 PRODUCT DOSE OMISSION 2 0.0000
954 DIZZINESS 15 0.0000
955 ABDOMINAL DISCOMFORT 5 0.0000
956 SINUSITIS 3 0.0000
957 MOBILITY DECREASED 2 0.0000
958 BLOOD GLUCOSE INCREASED 5 0.0000
959 GAIT DISTURBANCE 5 0.0000
960 PRURITUS 10 0.0000
961 WEIGHT DECREASED 7 0.0000
962 JOINT SWELLING 3 0.0000
963 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
964 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
965 INFLUENZA LIKE ILLNESS 2 0.0000
966 INJECTION SITE ERYTHEMA 3 0.0000
967 VISION BLURRED 3 0.0000
968 FATIGUE 17 0.0000
969 NEUROPATHY PERIPHERAL 2 0.0000
970 CONTUSION 2 0.0000
971 HEADACHE 13 0.0000
972 PAIN IN EXTREMITY 6 0.0000
973 DYSPEPSIA 2 0.0000
974 CHEST DISCOMFORT 2 0.0000
975 HOSPITALISATION 3 0.0000
976 PARAESTHESIA 3 0.0000
977 MYALGIA 3 0.0000
978 NASOPHARYNGITIS 3 0.0000
979 MALAISE 7 0.0000
980 PRODUCT QUALITY ISSUE 2 0.0000
981 MEMORY IMPAIRMENT 2 0.0000
982 WEIGHT INCREASED 3 0.0000
983 PERIPHERAL SWELLING 2 0.0000
984 DECREASED APPETITE 3 0.0000
985 DRUG DOSE OMISSION 2 0.0000
986 PRODUCT DOSE OMISSION ISSUE 3 0.0000
987 ALOPECIA 2 0.0000
988 INJECTION SITE PAIN 3 0.0000
989 ARTHRALGIA 4 0.0000
990 BACK PAIN 2 0.0000